Skip to main content
Clinical Trials/NCT03319108
NCT03319108
Completed
Not Applicable

The Effect of Severity of Co-morbidity on Outcomes of Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Patients

Izmir Katip Celebi University0 sites173 target enrollmentJanuary 2013
ConditionsCOPD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD
Sponsor
Izmir Katip Celebi University
Enrollment
173
Primary Endpoint
Exercise Capacity
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Our aim in this study is to determine the distribution of comorbidity in patients with COPD participating in the pulmonary rehabilitation program and to examine the effect of severity of comorbidy on pulmonary rehabilitation outcomes.

Detailed Description

Chronic Obstructive Pulmonary Disease (COPD) is associated not only with respiratory system effects but also with systemic outcomes leading to numerous chronic comorbidities, and it is well known that patients benefit from pulmonary rehabilitation programs. However, the effect of presence of comorbidity on the outcome of pulmonary rehabilitation in patients with COPD is not clear. Therefore, our aim in this study is to determine the distribution of comorbidity in patients with COPD participating in the pulmonary rehabilitation program and to examine the effect of severity of comorbidy on pulmonary rehabilitation outcomes We included a total of 173 patients referred to the Izmir Suat Seren Chest Diseases and Surgery Training and Research Hospital Pulmonary Rehabilitation Unit. Comorbidities were recorded based on self reports. Charlson Comorbid Indexes (CCI) were calculated. Patients who defined at least one comorbidity were divided into two groups according to CCI; 1-3 as Group 1 and 4 and above as Group 2. Six minute walk test, mMRC dyspnea scale, SGRQ Respiratory Disease Questionnaire, respiratory function tests and arterial blood gases performed for assessment of patients before and after 16 sessions of pulmonary rehabilitation program.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
February 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel

Investigators

Sponsor
Izmir Katip Celebi University
Responsible Party
Principal Investigator
Principal Investigator

Ilknur Naz

Asst. Prof.

Izmir Katip Celebi University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Exercise Capacity

Time Frame: 6 minute

Six minute walk test

Secondary Outcomes

  • Respiratory Functions(30 minutes)
  • Disease Specific Quality of Life(20 minutes)
  • Health Related Quality of Life(20 minutes)
  • Dyspnea(5 minutes)

Similar Trials